Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (131-140 of 271) with videos related to

Pageof 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastasesCameron Brennan, T Jonathan Yang, Patrick Hilden, et al.
Briefings in Bioinformatics|January 17, 2024
Unsupervised and supervised AI on molecular dynamics simulations reveals complex characteristics of HLA-A2-peptide immunogenicityJeffrey K Weber, Joseph A Morrone, Seung-Gu Kang, et al.
Oncotarget|January 6, 2017
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATMJennifer Ma, Jeremy Setton, Luc Morris, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic AstrocytomaJennifer Clarke, Elizabeth Neil, Robert Terziev, et al.
Nature Genetics|March 9, 2023
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitorsLuis Zapata, Giulio Caravagna, Marc J Williams, et al.
NPJ Precision Oncology|September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
Molecular Cancer Therapeutics|November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Neoplasia (New York, N.Y.)|April 10, 2022
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cellsSara Haddock, Tyler J Alban, Şevin Turcan, et al.
The Journal of Experimental Medicine|August 3, 2019
CD97 is a critical regulator of acute myeloid leukemia stem cell functionGaëlle H Martin, Nainita Roy, Sohini Chakraborty, et al.
Pageof 28

Showing results (131-140 of 271) with videos related to

Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastasesCameron Brennan, T Jonathan Yang, Patrick Hilden, et al.
Briefings in Bioinformatics|January 17, 2024
Unsupervised and supervised AI on molecular dynamics simulations reveals complex characteristics of HLA-A2-peptide immunogenicityJeffrey K Weber, Joseph A Morrone, Seung-Gu Kang, et al.
Oncotarget|January 6, 2017
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATMJennifer Ma, Jeremy Setton, Luc Morris, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic AstrocytomaJennifer Clarke, Elizabeth Neil, Robert Terziev, et al.
Nature Genetics|March 9, 2023
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitorsLuis Zapata, Giulio Caravagna, Marc J Williams, et al.
NPJ Precision Oncology|September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
Molecular Cancer Therapeutics|November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Neoplasia (New York, N.Y.)|April 10, 2022
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cellsSara Haddock, Tyler J Alban, Şevin Turcan, et al.
The Journal of Experimental Medicine|August 3, 2019
CD97 is a critical regulator of acute myeloid leukemia stem cell functionGaëlle H Martin, Nainita Roy, Sohini Chakraborty, et al.
Pageof 28